Dr. Charles Lemaistre is an oncologist practicing in San Antonio, TX. Dr. Lemaistre specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Lemaistre manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
University of Michigan Medical School 1979
University of Texas Southwestern Medical Center Southwestern Medical School 1979
- Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.
- Ex vivo-expanded hematopoietic cell graft recipients exhibit T cell repertoire diversity similar to that seen after conventional stem cell transplants.
- Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue.
- Ig heavy chain CDR3 size diversities are similar after conventional peripheral
- Two novel therapies for the treatment of cutaneous T-cell lymphoma.
- DAB(389)IL-2 (denileukin diftitox, ONTAK): other potential applications.
- Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.
- American Society for Blood and Marrow Transplantation guidelines for training.
- Therapeutic use of immunotoxins.
- Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.
- Initial clinical experiences with an interleukin-2 fusion toxin (DAB486-IL-2).
- Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation.
- Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
- Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.
- Liver transplantation for sinusoidal obstructive syndrome (veno-occlusive disease): case report with review of the literature and the UNOS database.
- Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.
- Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
- High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.
- High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.
- Prevention of cyclosporine-induced nephrotoxicity with transdermal clonidine.
- Longitudinal study of cyclosporine and lipids in patients undergoing bone marrow transplantation.
- Single-dose cyclosporine pharmacokinetics in various biological fluids of patients receiving allogeneic marrow transplantation.
- Mitoxantrone: potential for use in intensive therapy.
- Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.
- High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation Group.
- Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials.
- Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
- American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cel
- The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy.
- Autologous bone marrow transplantation in breast cancer. A panel discussion.
- Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature.
- High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors.
- Durable complete remission in a patient with refractory mediastinal non-seminomatous germ cell tumor after tandem high-dose chemotherapy and autologous bone marrow transplantation.
- High-dose melphalan allows durable engraftment of allogeneic bone marrow.
- Targeting the EGF receptor in breast cancer treatment.
- Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
- A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.
- Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow
- Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT.
- Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review.
- A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.
- Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
- Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2.
- Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
Dr. Charles F. Lemaistre M.D.'s Practice location
San Antonio, TX 78229Get Direction
Dr. Charles F. Lemaistre M.D.'s reviewsWrite Review
- Is a Mastectomy an Efficient Option to Treat Breast Cancer?
A mastectomy refers to the surgery performed to remove the breasts, either completely or partially. This was one of the traditional methods in the treatment of breast cancer for a long time. It is also used as a method to reduce the chances of developing breast cancer for women who have a high risk...
- What Is a Partial Hysterectomy?
In a Complete Hysterectomy, both the Uterus and Cervix are removed to afford symptomatic relief to the patient. When the Cervix remains in the pelvic region after surgery, it then becomes a Partial or Supracervical hysterectomy. The kind of surgery that one opts for is wholly dependent on the health...
- Ovarian Cancer Is Not Only Deadly, But Very Hard to Detect. Women Need to Stay Vigilant
September is known as Ovarian Cancer Awareness Month. Ovarian cancer is a type of cancer of the cells of the ovaries. It can occur in several different parts of the ovary, including the germ, stromal or epithelial cells. Germ cells are the cells that become eggs, stromal cells make up the substance...
- Cancers that Cause Blood in the Urine (Hematuria)
The presence of blood in the urine may be accompanied by pain during urination or it could also be painless. A painless hematuria may be caused by various health conditions such as cancers.Blood in the UrineThe presence of blood in the urine, may it be microscopic or gross, means something is wrong...
- Is Leukemia Painful?
Leukemia is considered to be a cancer of the blood cells and bone marrow, as the abnormality causes an increase in the growth of blood cells, particularly the white blood cells, which in time can over power the normal healthy blood cells. This leads to the manifestations of different signs and...
- Some Women May Benefit from Delaying Breast Reconstruction After Mastectomy, New Research Suggests
Mastectomy can be a daunting, but incredibly effective treatment for women who are diagnosed with breast cancer. In the surgery, all breast tissue is removed from the infected breast in an effort to treat or remove cancerous cells, but for women who undergo this surgery, the end result leaves much...
- Dr. Martin Andreansky MD, PHD1611 NW 12th Avenue Miami Florida 33136
- Frederick H. Hausheer8122 Datapoint Drive San Antonio Texas 78229
- Dr. Julie H. Rowe M.D.6410 Fannin Street Houston Texas 77030
- Dr. Irene Kazhdan M.D.1314 East Sonterra Boulevard San Antonio Texas 78258
- Dr. Muralidhar Beeram M.D.4383 Medical Dr San Antonio TX 78229
- Dr. Anand B Karnad M.D.7979 Wurzbach Rd San Antonio TX 78229